BIOFEFO-Z
Natural health product licensed in Canada
- Licence holder
- Nutri bio Pharma Inc. / Inov Pharma
- NPN or DIN-HM
- 80054891
- Status
- Active licence
- Licence date
- 16 October 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Fer: up to 15 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Zinc | 7.5 mg | 7,500 µg |
| Calcium Source : Calcium | 150 mg | 150,000 µg |
| Magnésium Source : Magnésium | 100 mg | 100,000 µg |
| Fer Source : Fer | 15 mg | 15,000 µg |
| Acide L-ascorbique Source : Vitamine C | 100 mg | Not calculated |
| Folate Source : Folate | 500 mcg | Not calculated |
| Cuivre Source : Cuivre | 900 mcg | 900 µg |
Non-medicinal ingredients
Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Aide à prévenir les carences en fer, aide au bon fonctionnement du système immunitaire, aide au bon développement des os. Le folate aide à réduire les risques de malformations du tube neuronal lorsqu'il est pris quotiennement avant ou dès le début de la grossese.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ne pas dépasser les doses recommandée.
Source
Official Health Canada record, licence 80054891
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.